The history of prescribing heroin and other injectable drugs as addiction treatment in the UK

Heroin Addiction and The British System

Volumn 2, Issue , 2004, Pages 1-16

  Strang, John ^a,b,c   Ruben, Susan ^d   Farrell, Michael ^c   Witton, John ^a   Keaney, Francis ^c   Gossop, Michael ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Angel Building   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d Liverpool Drug Dependency Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84909228882     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203643358     Document Type: Chapter

References (53)

1. ACMD (Advisory Council on the Misuse of Drugs) (1988). AIDS and drug misuse report. Part 1. HMSO, London.
2. ACMD (1989). AIDS and drug misuse report. Part 2. HMSO, London.
3. ACMD (1993). AIDS and drug misuse report. Update. HMSO, London.
4. Bammer, G., Dobler-Mikola, A., Fleming, P., Strang, J. and Uchtenhagen, A. (1999). The heroin prescribing debate: integrating science and politics. Science, 284: 1277-8.
5. Banks, A. and Waller, T.A.N. (1988). Drug misuse-a practical handbook for GPs. Blackwell Scientific Publications, Oxford.
6. Battersby, M., Farrell, M., Gossop, M., Robson, P. and Strang, J. (1992). 'Horsetrading': prescribing injectable opiates to opiate addicts. A descriptive study. Drug and Alcohol Review, 11,35-42.
7. Bewley, T.H. (1975). Evaluation of addiction treatment in England. In Drug dependence: treatment and treatment evaluation (ed. H. Bostrom, T. Larsson and N. Ljungstedt ), pp. 275-86. Almquist & Wiksell, Stockholm.
8. Blackwell, J. (1988). The saboteurs of Britain's opiate policy: over-prescribing physicians or American-style junkies? International Journal of the Addictions, 23, 517-26.
9. Blumberg, H., Cohen, S., Dronfield, B., Mardecai, E., Roberts, J. and Hawks, D. (1974). British opiate users: I. People approaching London drug treatment centres. International Journal of the Addictions, 9, 1-23.
10. Connell, P.H. (1975). Review of methadone maintenance schemes. In Drug dependence - treatment and treatment evaluation (ed. H. Bostrom, T. Larsson and N. Ljundstedt ), pp. 133-46. Almquist & Wiksell, Stockholm.
11. Dally, A. (1990). A doctor's story, Macmillan, London.
12. Department of Health and Social Security (1984). Guidelines for good clinical practice in the treatment of drug misuse. DHSS, London.
13. Department of Health, Scottish Home and Health Department, and Welsh Office (1991). Drug misuse and dependence: guidelines on clinical management, pp. 35-6. HMSO, London.
14. Derks, J. (1990). The efficacy of the Amsterdam morphine-dispensing programme. In Drug misuse and dependence (ed. A.H. Ghodse, C. Kaplan and R. Mann ), pp. 85-108. Parthenon, Carnforth.
15. Downes, D. (1977). The drug addict as folk devil. In Drugs and politics (ed. P. Rock ), pp. 89-97. Transaction Books, New Jersey.
16. Edwards, G. (1981). The Home Office Index as a basic monitoring system. In Drug problems in Britain: a review often years (ed. G. Edwards and C. Busch ), pp. 25-50. Academic Press, London.
17. Fischer, B., Rehm, J., Kirst, M., Hall, W., Krausz, M., Metribian, N., Reggers, J., Uchtenhagen, A., van den Brink, W. & van Ree, J.M. (2002). Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health, 12:228-34.
18. Gerada, C. and Murnane, M. (2003). Royal College of General Practitioners' Certificate in Drug Misuse. Drugs: Education, Prevention and Policy, 10:369-79.
19. Ghodse, A.H. (1992). Care of addicts in police custody. The Times, 25 February, p. 11.
20. Glanz, A., Byrne, C. and Jackson, P. (1989). Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. British Medical Journal, 209, 1076-9.
21. Guttinger, F., Gschwend, P., Schulte, B., Rehm, J., Uchtenhagen, A. (2003). Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. European Addiction Research, 9:73-9.
22. Hawks, D.V., Mitcheson, M., Ogborne, A. and Edwards, G. (1969). Abuse of methylamphetamine. British Medical Journal, 2, 715-21.
23. House of Commons (2002). The Government's drug policy: is it working? The Stationery Office, London.
24. Interdepartmental Committee on Drug Addiction (Brain Committee) (1965). Drug addiction; second report. HMSO, London.
25. James, I.P. (1968). A methylamphetamine epidemic. Lancet, i, 916.
26. Kools, J.P. (1992). Injectable methadone: policy for supplying methadone. Mainline: Drugs, Health and the Street (special edition), p. 5.
27. Metrebian, N., Carnwath, T., Stimson, G. and Storz, T. (2002). Survey of doctors prescribing diamorphine (heroin) to opiate-dependent drug users in the United Kingdom. Addiction, 97, 1155-61.
28. Ministry of Health (1926). Report of the Departmental Committee on Morphine and Heroin Addiction (Rolleston Report). HMSO, London.
29. Mitcheson, M. and Hartnoll, R. (1978). Conflicts in deciding treatments within drug dependency units. In Problems of drug abuse in Britain (ed. D.J. West ), pp. 74-9. Institute of Criminology, Cambridge.
30. Mitcheson, M., Edwards, G., Hawks, D. and Ogborne, A. (1976). Treatment of methylamphetamine users during the 1968 epidemic. In Drugs and drug dependence (ed. G. Edwards, M. Russell, D. Hawks and M. MacCafferty ), pp. 155-62. Saxon House, Farnborough.
31. O'Donnell, J.A. and Jones, J.D. (1968). Diffusion of the intravenous technique among narcotic addicts. Journal of Health and Social Behaviour, 9, 120-30.
32. Perneger, T.V., Giner, F., del Rio M. and Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in coinventional drug treatments. British Medical Journal, 317:13-18.
33. Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A., & Uchtenhagen, A. (2001). Feasibility, safety and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet, 358:1417-23.
34. Robertson, R. (1987). Heroin, AIDS and society. Hodder & Stoughton, London.
35. Self, W. (1995). Drug dealer by appointment to H.M. Government. In Junk Mail, pp. 83-91. Penguin: London.
36. Smart, C. (1984). Social policy and drug addiction: a critical study of policy development. British Journal of Addiction, 79, 31-9.
37. Stimson, G.V. (1973). Heroin and behaviour: diversity among addicts attending London clinics. Irish University Press, Shannon.
38. Stimson, G.V. and Oppenheimer, E. (1982). Heroin addiction: treatment and control in Britain. Tavistock, London.
39. Stimson, G., Alldritt, L., Dolan, K. and Donoghoe, M. (1988). Syringe exchange schemes for drug users in England and Scotland. British Medical Journal, 296, 1717-19.
40. Stimson, G., Donoghoe, M., Lart, R. and Dolan, K. (1990). Distributing sterile needles and syringes to people who inject drugs: the syringe exchange experiment. In AIDS and drug misuse: the challenge for policy and practice in the 1990s (ed. J. Strang and G. Stimson ), pp. 222-31. Routledge, London.
41. Stoermer, R., Drewe, J., Dursteler-MacFarland, K.M., Hock, C., Mueller-Spahn, F., Ladewig, D., Stohler, R. and Mager, R. (2003). Safety of injectable opioid maintenance treatment for heroin dependence. Biological Psychiatry, 54:854-61.
42. Stohler, R., Dursteler, K.M., Stoermer, R., Seifritz, E., Hug, I., Sattler-Mayr, J., Muller-Spahn, F., Ladewig, D. and Hock, C. (1999). Rapid cortical hemoglobin deoxygenation after heroin and methadone injection in humans: a preliminary report. Drug and Alcohol Dependence, 57:23-8.
43. Strang, J. (1990). The roles of prescribing. In AIDS and drug misuse: the challenge for policy and practice in the 1990s (ed. J. Strang and G. Stimson ), pp. 142-52. Routledge, London.
44. Strang, J. (1992). Harm reduction for drug users: exploring the dimensions of harm, their measurement and the strategies for reduction. AIDS and Public Policy Journal, 7(3), 145-52.
45. Strang, J. (1993). Drug use and harm reduction: responding to the challenge. In Harm reduction: from faith to science (ed. N. Heather, A. Wodak, E. Nadelman and P. O'Hare ), pp. 3-20. Whurr Publishers, London.
46. Strang, J. and Gossop, M. (eds) (1994). Heroin addiction and drug policy: the British system. Oxford University Press, Oxford.
47. Strang, J. and Sheridan, J. (1997). Heroin prescribing in the 'British System' of the mid 1990s: data from the 1995 national survey of community pharmacies in England and Wales. Drug and Alcohol Review, 16:7-16.
48. Strang, J. and Sheridan, J. (1998). National and regional characteristics of methadone prescribing in England and Wales: local analyses of data from the 1995 national survey of community pharmacies. Journal of Substance Misuse, 3:240-6.
49. Strang, J. and Sheridan, J. (2003). Injectable methadone prescribing: a peculiarly British treatment. In Methadone matters-evolving community methadone treatment of opiate addiction (ed. G. Tober and J. Strang ), pp. 91-105. Dunitz, London.
50. Strang, J. and Stimson, G. (1990). The impacts of HIV: forcing the process of change. In AIDS and drug misuse: the challenge for policy and practice in the 1990s (ed. J. Strang and G. Stimson ), pp. 3-15. Routledge, London.
51. Strang, J., Sheridan, J., Barber, N. and Glanz, A. (1996). Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales. British Medical Journal, 313:272-4.
52. Tober, G. and Strang, J. (eds) (2003). Methadone matters-evolving community methadone treatment of opiate addiction. Dunitz, London.
53. Van den Brink, W., Hendriks, V.M., Blanken, P., Koeter, M.W., van Zwieten, B.J., and van Ree, J.M. (2003). Medical prescription of heroin to treatment resistant heroin addicts: two randomized controlled trials. British Medical Journal, 327:310.